KoBioLabs, Inc (KOSDAQ:348150)

KoBioLabs Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	96,318	103,844	160,602	191,231	335,174	672,727
Market Cap Growth	-35.34%	-35.34%	-16.02%	-42.95%	-50.18%	-
Enterprise Value	74,680	80,193	121,886	127,584	294,643	650,116
Last Close Price	4960.00	5360.00	8510.00	11050.00	20600.00	43350.00
PS Ratio	1.41	1.52	4.85	16.48	115.84	146.52
PB Ratio	1.74	1.87	2.60	2.00	3.70	12.15
P/TBV Ratio	2.59	2.79	3.65	2.51	3.75	12.21
EV/Sales Ratio	1.09	1.17	3.68	10.99	101.84	141.59
Debt / Equity Ratio	0.30	0.30	0.30	0.14	0.10	0.00
Asset Turnover	0.63	0.63	0.28	0.10	0.04	0.10
Inventory Turnover	7.27	7.27	7.72	5.88	5.50	17.11
Quick Ratio	4.28	4.28	3.36	10.95	13.45	18.17
Current Ratio	4.82	4.82	3.58	11.46	14.42	18.71
Return on Equity (ROE)	-7.87%	-7.87%	-19.28%	-25.14%	-21.07%	-1173.43%
Return on Assets (ROA)	-3.98%	-3.98%	-9.67%	-11.07%	-12.47%	-16.44%
Return on Capital (ROIC)	-5.67%	-5.67%	-12.19%	-12.13%	-13.15%	-161.09%
Earnings Yield	-5.50%	-5.10%	-8.63%	-11.46%	-4.59%	-8.19%
FCF Yield	-6.22%	-5.77%	-18.04%	-16.34%	-5.37%	-1.92%
Buyback Yield / Dilution	-3.54%	-3.54%	-10.30%	-4.68%	-49.69%	-51.75%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.